Saturday, Oct 21 2017 | Updated at 08:19 AM EDT

Stay Connected With Us F T R

Lin BioScience

University Of Sydney Gets Exclusive License For Brain Cancer Medicine

Mar 27, 2017 PM EDT Lin BioScience confirms an exclusive license agreement with the University of Sydney for a very promising brain cancer drug.

Real Time Analytics